Annals of Surgical Oncology

, Volume 15, Issue 5, pp 1440–1446 | Cite as

Discordant Histology of Primary Appendiceal Adenocarcinoid Neoplasms with Peritoneal Dissemination

  • Tristan D. Yan
  • Erwin A. Brun
  • Paul H. Sugarbaker
Gastrointestinal Oncology

ABSTRACT

Background

Adenocarcinoid is a rare appendiceal tumor that shows histologically both epithelial and neuroendocrine components. We observed that some patients have peritoneal dissemination, which shows adenocarcinoma but lacks the neuroendocrine histology. The objective of the present study was to quantitate these discordant histopathological findings and examine its clinical implication.

Methods

Twenty-six patients with peritoneal dissemination from primary appendiceal adenocarcinoid tumors underwent cytoreductive surgery and perioperative intraperitoneal chemotherapy. All resected specimens were individually submitted for histopathological examination and immunostaining with three neuroendocrine markers. The anatomic locations for peritoneal implants were prospectively recorded. The loss of the neuroendocrine tumor type in peritoneal implants was referred to as discordant feature of the adenocarcinoid tumor. Clinical and histopathological prognostic factors for survival were analyzed.

Results

In nine of the 26 patients (35%) with a primary adenocarcinoid of the appendix, a loss of the neuroendocrine immunochemical marker was noted in peritoneal implants. Discordant histology between the primary appendiceal adenocarcinoid and the peritoneal implants was statistically significantly associated with an improved survival (p = 0.0262), when patients were treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.

Conclusions

Discordant histology of the primary appendiceal tumor as compared to the peritoneal lesions occurs frequently in patients with adenocarcinoid. An assessment of neuroendocrine markers in both primary and peritoneal lesions may help in the clinical assessment of this group of patients. Small numbers of patients were available for this study and the conclusions are therefore limited.

Keywords

Adenocarcinoid Goblet cell carcinoid Appendiceal neoplasms Discordant Cytoreduction Perioperative intraperitoneal chemotherapy 

References

  1. 1.
    Chang P, Attiyeh FF. Adenocarcinoma of the appendix. Dis Colon Rectum 1981;24:176–80PubMedCrossRefGoogle Scholar
  2. 2.
    Warkel RL, Cooper PH, Helwig EB. Adenocarcinoid, a mucin-producing carcinoid tumor of the appendix: a study of 39 cases. Cancer 1978;42:2781–93PubMedCrossRefGoogle Scholar
  3. 3.
    Rutledge RH, Alexander JW. Primary appendiceal malignancies: rare but important.[see comment]. Surgery 1992;111:244–50PubMedGoogle Scholar
  4. 4.
    Edmonds P, Merino MJ, LiVolsi VA, et al. Adenocarcinoid (mucinous carcinoid) of the appendix. Gastroenterology 1984;86:302–9PubMedGoogle Scholar
  5. 5.
    Gagne F, Fortin P, Dufour V, et al. [Tumors of the appendix associating histologic features of carcinoid and adenocarcinoma]. Ann Anat Pathol (Paris) 1969;14:393–406Google Scholar
  6. 6.
    Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol 1995;19:1390–408PubMedCrossRefGoogle Scholar
  7. 7.
    Misdraji J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003;27:1089–103PubMedCrossRefGoogle Scholar
  8. 8.
    Yan H, Pestieau SR, Shmookler BM, et al. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation. Mod Pathol 2001;14:164–71PubMedCrossRefGoogle Scholar
  9. 9.
    Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82:359–74PubMedGoogle Scholar
  10. 10.
    Sugarbaker P. Peritonectomy procedures. Ann Surg 1995;221:29–42PubMedGoogle Scholar
  11. 11.
    Subbuswamy SG, Gibbs NM, Ross CF, et al. Goblet cell carcinoid of the appendix. Cancer 1974;34:338–344PubMedCrossRefGoogle Scholar
  12. 12.
    Hofler H, Kloppel G, Heitz PU. Combined production of mucus, amines and peptides by goblet-cell carcinoids of the appendix and ileum. Pathol Res Pract 1984;178:555–61PubMedGoogle Scholar
  13. 13.
    Chen V, Qizilbash AH. Goblet cell carcinoid tumor of the appendix. Report of five cases and review of the literature. Arch Pathol Lab Med 1979;103:180–2PubMedGoogle Scholar
  14. 14.
    Klappenbach RS, Kurman RJ, Sinclair CF, et al. Composite carcinoma-carcinoid tumors of the gastrointestinal tract. A morphologic, histochemical, and immunocytochemical study. Am J Clin Pathol 1985;84:137–43PubMedGoogle Scholar
  15. 15.
    Levendoglu H, Cox CA, Nadimpalli V. Composite (adenocarcinoid) tumors of the gastrointestinal tract. Dig Dis Sci 1990;35:519–25PubMedCrossRefGoogle Scholar
  16. 16.
    Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 1987;11:71–86PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2008

Authors and Affiliations

  • Tristan D. Yan
    • 1
  • Erwin A. Brun
    • 2
  • Paul H. Sugarbaker
    • 1
  1. 1.Peritoneal Surface Malignancy Program, Washington Cancer InstituteWashington Hospital CenterWashingtonUSA
  2. 2.Department of PathologyWashington Hospital CenterWashingtonUSA

Personalised recommendations